Low-dose dopamine induces early recovery of recombinant interleukin-2—Impaired renal function
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (8) , 1119-1122
- https://doi.org/10.1016/s0959-8049(05)80300-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosisHepatology, 1991
- Interleukin-2 toxicity.Journal of Clinical Oncology, 1991
- Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer PatientsAnnals of Surgery, 1989
- New Approaches to the Immunotherapy of Cancer Using Interleukin-2Annals of Internal Medicine, 1988
- Nephrotoxicity of continuous intravenous infusion of recombinant interleukin-2The American Journal of Medicine, 1988
- Effects of Interleukin-2 on Renal Function in Patients Receiving Immunotherapy for Advanced CancerAnnals of Internal Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Effect of Intravenous Infusion of Low-Dose Dopamine on Renal Function in Normal Individuals and in Patients with Renal DiseaseAmerican Journal of Nephrology, 1986
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1984
- Dopamine and the KidneyClinical Science, 1982